Tag Archives: COVID-19

University of Glasgow Appoints Professor Emma Thomson as Permanent Director of CVR, Leading Advancements in Virus Research

(IN BRIEF) The University of Glasgow has appointed Professor Emma Thomson as the new Director of the MRC-University of Glasgow Centre for Virus Research (CVR), after she served as Interim Director from February. An expert in emerging infectious diseases, Professor … Read the full press release

Itepekimab Shows Positive Results in COPD Phase 3 Study, Reducing Exacerbations in AERIFY-1 Trial

(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release

University of York Researchers Secure £4.5 Million Wellcome Discovery Award to Expand Born in Bradford Study

(IN BRIEF) The University of York’s team has secured a £4.5 million Wellcome Discovery Award to extend the Born in Bradford research programme, which will now study 8,000 children and their families in Bradford. Building on the success of the … Read the full press release

University of Warwick’s Dr. Alex Baker Wins 2025 British Science Association Award for Excellence in Physical Sciences and Mathematics

(IN BRIEF) Dr. Alex Baker, Assistant Professor of Chemistry at The University of Warwick, has been named the winner of the 2025 British Science Association’s Physical Sciences and Mathematics Award Lecture. The award recognizes his exceptional research in Neglected Tropical … Read the full press release

AstraZeneca Unveils Breakthrough Data on Vaccines and Antibody Therapies for Infections

(IN BRIEF) At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featuring 13 abstracts across oral and poster presentations. The Company aims to demonstrate its progress in developing innovative … Read the full press release

University of Groningen Researcher Moniek Tromp Innovates with Tabletop Spectroscope to Advance Sustainable Battery Research

(IN BRIEF) Moniek Tromp, a researcher at the University of Groningen, has developed a portable, tabletop spectroscope to accelerate her research on sustainable battery technology. This innovation allows her to conduct vital measurements on batteries in her own lab, bypassing … Read the full press release

Professor Massimo Palmarini Steps Down as Director of CVR, Professor Emma Thomson Named Interim Director

(IN BRIEF) After over a decade of leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini is stepping down as Director to take on the role of Head of Viroscience at Erasmus University Medical Centre in … Read the full press release

DAAD Unveils Strategy 2030 to Navigate Geopolitical Shifts and Strengthen Germany’s Role in Global Academia

(IN BRIEF) The German Academic Exchange Service (DAAD) has launched its Strategy 2030 to address significant geopolitical changes and strengthen Germany’s position as a leader in global academia. The strategy focuses on four key priorities: enhancing Germany’s role in science, … Read the full press release

NWO Warns of Harmful Impact of Proposed Budget Cuts on Dutch Education and Research Sector

(IN BRIEF) This week, the Dutch Senate is deliberating the 2025 budget, which includes significant cuts to higher education and scientific research. NWO has expressed concern that these reductions will hinder the Netherlands’ ability to remain competitive as a knowledge-based … Read the full press release

AstraZeneca’s Calquence Gains U.S. Approval for First-Line Treatment of Mantle Cell Lymphoma, Following Positive Phase III Results

(IN BRIEF) AstraZeneca’s Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation. The approval is based on … Read the full press release

AstraZeneca Presents New Data at IDWeek 2024, Showcasing Progress in Respiratory Disease Prevention and Vaccine Innovation

(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, and COVID-19. The company revealed promising data across its portfolio, including Beyfortus, an antibody … Read the full press release

Pfizer and BioNTech Report Promising Results for mRNA-Based Combination Vaccine Against Influenza and COVID-19

(IN BRIEF) Pfizer and BioNTech have announced positive topline results from a Phase 1/2 study of their mRNA-based combination vaccine program for influenza and COVID-19. The lead formulations showed robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains. … Read the full press release

EMA Backs Comirnaty Omicron XBB.1.5 Vaccine for Varied Ages Amid Variant Concerns

(IN BRIEF) EMA proposes Comirnaty Omicron XBB.1.5 vaccine for ages 6 months+, tailored to combat Omicron XBB.1.5 variant. One dose suffices for ages 5+, while kids 6 months to 4 years may need 1 or 3 doses based on prior … Read the full press release

Bi-Regional Cooperation: H.M. King Felipe VI Welcomes the 15th meeting of the EuroLat Assembly in Madrid from 24th to 27th July, 2023

(IN BRIEF) The Euro-Latin American Parliamentary Assembly (EuroLat) is set to hold its fifteenth meeting in Madrid from 24th to 27th July. The gathering will bring together 75 Members of the European Parliament (MEPs) and 75 representatives from Latin American … Read the full press release

Roche announces a regulatory milestone for its cobas SARS-CoV-2 Qualitative PCR test for use on the fully automated cobas 6800 and 8800 analyzer systems

The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k) clearance. This FDA clearance will ensure that the healthcare community has access to timely, reliable and accurate COVID-19 PCR testing … Read the full press release

Roche annonce une étape réglementaire importante pour son test PCR qualitatif cobas SARS-CoV-2 à utiliser sur les systèmes d’analyseurs cobas 6800 et 8800 entièrement automatisés

Le test qualitatif cobas SARS-CoV-2 est l’un des premiers tests PCR COVID-19 effectués sur une plateforme automatisée à haut débit à recevoir l’autorisation FDA 510(k). Cette autorisation de la FDA garantira que la communauté des soins de santé a accès … Read the full press release

Thetius / Inmarsat report: COVID-19 seens as universal disruptor and catalyst for digital transformation in the shipping industry

‘A Changed World’ details the fast tracking of IoT-based solutions in post-pandemic world (PRESS RELEASE) LONDON, 13-Oct-2021 — /EuropaWire/ — Inmarsat (LSE: ISAT), the world leader in global, mobile satellite communications, has released a new report that looks into how the … Read the full press release

AstraZeneca, EU agree to end legal proceedings over the delivery of the COVID-19 vaccine Vaxzevria

(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an agreement between the Company and the European Commission has been reached that puts an end of the legal proceedings over … Read the full press release

Vodacom’s e-health policy paper: exponential rise in the number of people across Africa relying on Internet for health information

New study shows huge opportunity in digital health with 41% of internet users in Africa regularly using their mobile phones to search for health information (PRESS RELEASE) BERKSHIRE, 24-Aug-2021 — /EuropaWire/ — Vodacom Group Limited (JSE: VOD), a South African … Read the full press release

Lloyds Bank survey: UK businesses demonstrated incredible resilience over the pandemic period, case studies

Business across the UK (48%) report that the pandemic sparked a wave of creative thinking. Manufacturing firms were the most likely to adapt through changes to their operating patterns (28%) and expanding the product offering (22%). London (63%) and North … Read the full press release